Robert Likić (Ivan Krecak, Robert Likic)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 58

Top Topics

Medical Students

Respiratory Syndrome Coronavirus

Artificial Intelligence

Metastatic Breast Cancer

Top Venues

British journal of clinical pharmacology

Postgraduate medical journal

Rheumatology international

Wiener klinische Wochenschrift

This page only lists publications with an associated author ORCID identifier.

Publications

Igor Rubinić, Marija Kurtov, Robert Likić
Novel Pharmaceuticals in Appetite Regulation: Exploring emerging gut peptides and their pharmacological prospects. Pharmacology research & perspectives 12 (4) (2024)
Marko Lucijanic, Robert Likić
The future is now, old man. British journal of clinical pharmacology 90 (3) (2024)
Katarzyna Dubas-Jakóbczyk, Ana Isabel Gonzalez, Alicja Domagała, María Pilar Astier Peña, Veronica Casado Vicente, Antonia-Gema Planet, Agueda Quadrado, Rosa Mari Serrano, Isabel Serafina Abellán, Alba Ramos, Marta Ballester, Laura Alexandra Seils, Sorin-Adrian Dan, Linda E Flinterman, Robert Likić, Ronald Batenburg
Medical deserts in Spain-Insights from an international project. The International journal of health planning and management (2024)
Marko Lucijanic, Robert Likic, Robert Likić
Delayed diagnosis of nonspecific symptoms requiring overdiagnosis and overtreatment? Wiener klinische Wochenschrift 136 (7-8) (2024)
Katarzyna Dubas-Jakóbczyk, Ana Isabel Gonzalez, Alicja Domagała, María Pilar Astier Peña, Veronica Casado Vicente, Antonia-Gema Planet, Agueda Quadrado, Rosa Mari Serrano, Isabel Serafina Abellán, Alba Ramos, Marta Ballester, Laura Alexandra Seils, Sorin-Adrian Dan, Linda E Flinterman, Robert Likić, Ronald Batenburg
Medical deserts in Spain-Insights from an international project. The International journal of health planning and management (2024)
Marko Lucijanic, Robert Likic, Robert Likić
Delayed diagnosis of nonspecific symptoms requiring overdiagnosis and overtreatment? Wiener klinische Wochenschrift (2024)
Katarzyna Dubas-Jakóbczyk, Ana Isabel Gonzalez, Alicja Domagała, María Pilar Astier Peña, Veronica Casado Vicente, Antonia-Gema Planet, Agueda Quadrado, Rosa Mari Serrano, Isabel Serafina Abellán, Alba Ramos, Marta Ballester, Laura Alexandra Seils, Sorin-Adrian Dan, Linda E Flinterman, Robert Likić, Ronald Batenburg
Medical deserts in Spain-Insights from an international project. The International journal of health planning and management 39 (3) (2024)
Marko Lucijanic, Robert Likić
The future is now, old man. British journal of clinical pharmacology 90 (3) (2024)
Marko Lucijanic, Robert Likić
The future is now, old man. British journal of clinical pharmacology 90 (3) (2024)
Marko Lucijanic, Robert Likic, Robert Likić
Delayed diagnosis of nonspecific symptoms requiring overdiagnosis and overtreatment? Wiener klinische Wochenschrift 136 (7-8) (2024)
Marija Kurtov, Igor Rubinić, Robert Likić
The endocannabinoid system in appetite regulation and treatment of obesity. Pharmacology research & perspectives 12 (5) (2024)
Marko Lucijanic, Robert Likić
The future is now, old man. British journal of clinical pharmacology (2024)
Igor Rubinić, Marija Kurtov, Robert Likić
Novel Pharmaceuticals in Appetite Regulation: Exploring emerging gut peptides and their pharmacological prospects. Pharmacology research & perspectives 12 (4) (2024)
Karlo Petkovic, Zdeslav Strika, Robert Likić, Marko Lucijanic
Spotlight commentary: Integrating artificial intelligence in clinical pharmacology: Opportunities, challenges and ethical imperatives. British journal of clinical pharmacology (2024)
Linda E Flinterman, Ana Isabel Gonzalez, Laura Alexandra Seils, Julia Bes, Marta Ballester, Joaquim Bañeres, Sorin-Adrian Dan, Alicja Domagała, Katarzyna Dubas-Jakóbczyk, Robert Likić, Marieke Kroezen, Ronald Batenburg
Characteristics of Medical Deserts and Approaches to Mitigate Their Health Workforce Issues: A Scoping Review of Empirical Studies in Western Countries. International journal of health policy and management 12 (2023)
Igor Rubinic, Marija Kurtov, Ivan Rubinic, Robert Likić, Paul I Dargan, David M Wood
Artificial Intelligence in Clinical Pharmacology: A Case Study and Scoping Review of Large Language Models and Bioweapon Potential. British journal of clinical pharmacology (2023)
Robert Marcec, Robert Likić
Using Twitter for sentiment analysis towards AstraZeneca/Oxford, Pfizer/BioNTech and Moderna COVID-19 vaccines. Postgraduate medical journal 98 (1161) (2023)
Elena Primorac Padjen, Robert Marcec, Matija Zidar, Ivan Padjen, Tomislav Katanec, Branimir Anić, Robert Likić
Comparison of reporting rates of arthritis and arthralgia following AstraZeneca, Pfizer-BioNTech, Moderna, and Janssen vaccine administration against SARS-CoV-2 in 2021: analysis of European pharmacovigilance large-scale data. Rheumatology international 44 (2) (2023)
Linda E Flinterman, Ana Isabel Gonzalez, Laura Alexandra Seils, Julia Bes, Marta Ballester, Joaquim Bañeres, Sorin-Adrian Dan, Alicja Domagała, Katarzyna Dubas-Jakóbczyk, Robert Likić, Marieke Kroezen, Ronald Batenburg
Characteristics of Medical Deserts and Approaches to Mitigate Their Health Workforce Issues: A Scoping Review of Empirical Studies in Western Countries. International journal of health policy and management 12 (2023)
Elena Primorac Padjen, Robert Marcec, Matija Zidar, Ivan Padjen, Tomislav Katanec, Branimir Anić, Robert Likić
Comparison of reporting rates of arthritis and arthralgia following AstraZeneca, Pfizer-BioNTech, Moderna, and Janssen vaccine administration against SARS-CoV-2 in 2021: analysis of European pharmacovigilance large-scale data. Rheumatology international 44 (2) (2023)
Robert Marcec, Fran Posavec, Robert Likić
Vitamin C utilisation in 2020: have we bought a lemon? Postgraduate medical journal 98 (1163) (2023)
Elena Primorac Padjen, Robert Marcec, Matija Zidar, Ivan Padjen, Tomislav Katanec, Branimir Anić, Robert Likić
Comparison of reporting rates of arthritis and arthralgia following AstraZeneca, Pfizer-BioNTech, Moderna, and Janssen vaccine administration against SARS-CoV-2 in 2021: analysis of European pharmacovigilance large-scale data. Rheumatology international 44 (2) (2023)
Michiel J Bakkum, Mariëlle G Hartjes, Joost D Piët, Erik M Donker, Robert Likić, Emílio J Sanz, Fabrizio de Ponti, Petra Verdonk, Milan C Richir, Michiel A van Agtmael, Jelle Tichelaar
Using artificial intelligence to create diverse and inclusive medical case vignettes for education. British journal of clinical pharmacology (2023)
Robert Marcec, Laura Alexandra Seils, Ana Isabel Gonzalez, Katarzyna Dubas-Jakóbczyk, Alicja Domagała, Sorin-Adrian Dan, Linda E Flinterman, Robert Likić, Ronald Batenburg
Tackling medical deserts: unearthing factors that influence medical students' attitudes and the path forward. Postgraduate medical journal (2023)
Linda E Flinterman, Ana Isabel Gonzalez, Laura Alexandra Seils, Julia Bes, Marta Ballester, Joaquim Bañeres, Sorin-Adrian Dan, Alicja Domagała, Katarzyna Dubas-Jakóbczyk, Robert Likić, Marieke Kroezen, Ronald Batenburg
Characteristics of Medical Deserts and Approaches to Mitigate Their Health Workforce Issues: A Scoping Review of Empirical Studies in Western Countries. International journal of health policy and management 12 (2023)
Elena Primorac Padjen, Robert Marcec, Matija Zidar, Ivan Padjen, Tomislav Katanec, Branimir Anić, Robert Likić
Comparison of reporting rates of arthritis and arthralgia following AstraZeneca, Pfizer-BioNTech, Moderna, and Janssen vaccine administration against SARS-CoV-2 in 2021: analysis of European pharmacovigilance large-scale data. Rheumatology international (2023)
Luka Sizgoric, Robert Likić
Proton pump inhibitors: Weighing the benefits and risks across various health conditions. British journal of clinical pharmacology (2023)
Michiel J Bakkum, Bryan J Loobeek, Milan C Richir, Paraskevi Papaioannidou, Robert Likić, Emílio J Sanz, Thierry Christiaens, João N Costa, Lorena Dima, Fabrizio de Ponti, Cornelis Kramers, Jeroen van Smeden, Michiel A van Agtmael, Jelle Tichelaar, null null
Teaching resources for the European Open Platform for Prescribing Education (EurOP 2 E)-a nominal group technique study. NPJ science of learning 7 (1) (2022)
Robert Marcec, Vinko Michael Dodig, Igor Radanovic, Robert Likić
Intravenous immunoglobulin (IVIg) therapy in hospitalised adult COVID-19 patients: A systematic review and meta-analysis. Reviews in medical virology 32 (6) (2022)
Robert Likić, James W Dear, Lionel D Lewis
Spotlight commentary: Navigating between financial risks and improved treatment outcomes with immune checkpoint inhibitors in cancer patients: The need for biomarker identification and dose optimization. British journal of clinical pharmacology 88 (12) (2022)
Robert Marcec, Josip Stjepanovic, Robert Likić
Seasonality of Hashimoto Thyroiditis: Infodemiology Study of Google Trends Data. JMIR bioinformatics and biotechnology 3 (1) (2022)
Robert Marcec, Robert Likić
Could Fluvoxamine Dose De-escalation Increase Treatment Compliance Without Sacrificing Efficacy in COVID-19 Patients? Clinical pharmacokinetics 61 (9) (2022)
Michiel J Bakkum, Petra Verdonk, Elias G Thomas, Floor van Rosse, Michael Okorie, Paraskevi Papaioannidou, Robert Likić, Emílio J Sanz, Thierry Christiaens, João N Costa, Lorena Dima, Fabrizio de Ponti, Jeroen van Smeden, Michiel A van Agtmael, Milan C Richir, Jelle Tichelaar, null null
A Clinical Pharmacology and Therapeutics Teacher's Guide to Race-Based Medicine, Inclusivity, and Diversity. Clinical pharmacology and therapeutics (2022)
Spoorthy Kulkarni, Michael J Rieder, Robert Likić
Quo vadis (where are you going) pharmacovigilance? British journal of clinical pharmacology (2022)
Nika Filipovic, Robert Likić, Vedrana Bulat, Slavko Gašparov, Marija Delas Azdajic
Brentuximab-induced splinter nail haemorrhages in a patient with Sézary syndrome: A case report. British journal of clinical pharmacology 88 (8) (2022)
Robert Marcec, Fran Posavec, Robert Likić
Vitamin C utilisation in 2020: have we bought a lemon? Postgraduate medical journal (2022)
Robert Marcec, Matea Majta, Robert Likić
Brave, new and divided post-COVID-19 world. Postgraduate medical journal 98 (e2) (2022)
Robert Marcec, Josip Stjepanovic, Robert Likić
Seasonality of Hashimoto Thyroiditis: Infodemiology Study of Google Trends Data. JMIR bioinformatics and biotechnology 3 (1) (2022)
Robert Marcec, Robert Likić
Using Twitter for sentiment analysis towards AstraZeneca/Oxford, Pfizer/BioNTech and Moderna COVID-19 vaccines. Postgraduate medical journal (2021)
Marko Boskovic, William Migo, Robert Likić
SARS-CoV-2 mutations: A strain on efficacy of neutralizing monoclonal antibodies? British journal of clinical pharmacology 87 (11) (2021)
Charles E Leonard, James H Flory, Robert Likić, Olayinka O Ogunleye, Li Wei, Ian Wong
Spotlight commentary: A role for real-world evidence to inform the clinical care of patients with diabetes mellitus. British journal of clinical pharmacology (2021)
Robert Marcec, Robert Likić
Postvaccination anaphylaxis and mRNA-based SARS-CoV-2 vaccines-Much ado about nothing? British journal of clinical pharmacology 87 (9) (2021)
Michiel J Bakkum, Milan C Richir, Paraskevi Papaioannidou, Robert Likić, Emílio J Sanz, Thierry Christiaens, João N Costa, Romaldas Mačiulaitis, Lorena Dima, Jamie J Coleman, Jelle Tichelaar, Michiel A van Agtmael, null null
EurOP2E - the European Open Platform for Prescribing Education, a consensus study among clinical pharmacology and therapeutics teachers. European journal of clinical pharmacology 77 (8) (2021)
Vedrana Bulat, Robert Likić, Nives Pondeljak, Marija Delas Azdajic
Pholcodine-induced Stevens-Johnson syndrome in a patient with COVID-19. Postgraduate medical journal (2021)
Martina Calusic, Robert Marcec, Lea Luksa, Ivan Jurkovic, Natasa Kovac, Slobodan Mihaljevic, Robert Likić
Safety and efficacy of fluvoxamine in COVID-19 ICU patients: An open label, prospective cohort trial with matched controls. British journal of clinical pharmacology (2021)
Igor Radanovic, Robert Likić, Geert Jan Groeneveld
Spotlight Commentary: Importance of dose redefining in the process of drug repurposing. British journal of clinical pharmacology 87 (4) (2020)
Michiel J Bakkum, Jelle Tichelaar, Paraskevi Papaioannidou, Robert Likić, Emílio J Sanz, Thierry Christiaens, João N Costa, Romaldas Mačiulaitis, Lorena Dima, Jamie J Coleman, Milan C Richir, Michiel A van Agtmael, null null
Harmonizing and improving European education in prescribing: An overview of digital educational resources used in clinical pharmacology and therapeutics. British journal of clinical pharmacology 87 (3) (2020)
James N Fullerton, Oscar Della Pasqua, Robert Likić
Model antibiotic use to improve outcomes. British journal of clinical pharmacology 87 (3) (2020)
Robert Marcec, Matea Majta, Robert Likić
Brave, new and divided post-COVID-19 world. Postgraduate medical journal (2020)
Vedrana Bulat, Mirna Situm, Marija Delas Azdajic, Robert Likić
Potential role of IL-17 blocking agents in the treatment of severe COVID-19? British journal of clinical pharmacology 87 (3) (2020)
Robert Likić
Sustainability of costs of novel biologicals: Are we all heading for bankruptcy? British journal of clinical pharmacology 86 (7) (2020)
Vedrana Bulat, Robert Likić, Lada Bradic, Reinhart Speeckaert, Marija Delas Azdajic
Pembrolizumab-induced vitiligo in a patient with lung adenocarcinoma: A case report. British journal of clinical pharmacology 87 (6) (2020)
Robert Marcec, Matea Majta, Robert Likić
Will vaccination refusal prolong the war on SARS-CoV-2? Postgraduate medical journal 97 (1145) (2020)
Karla Margetic, Teo Miric, Eric Nham, Robert Likić
Attitudes of final year medical students towards work in rural areas could be a problem for Croatian tourism. Postgraduate medical journal 95 (1127) (2019)
Darija Grebenar, Eric Nham, Robert Likić
Factors influencing pharmacists' over-the-counter drug recommendations. Postgraduate medical journal 96 (1133) (2019)
Luka Bielen, Robert Likić
Experience with fosfomycin in the treatment of complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae. Therapeutic advances in infectious disease 6 (2019)
Igor Radanović, Robert Likić
Opportunities for Use of Blockchain Technology in Medicine. Applied health economics and health policy 16 (5) (2019)
August Cesarec, Robert Likić
Budget Impact Analysis of Biosimilar Trastuzumab for the Treatment of Breast Cancer in Croatia. Applied health economics and health policy 15 (2) (2017)